Nichi-Iko Establishes Joint Venture With Mitani To Produce Generic Drug APIs
This article was originally published in PharmAsia News
Executive SummaryJapanese generic drug maker Nichi-Iko May 11 signed an agreement with Mitani Sangyo to establish a ¥300 million joint venture to produce active pharmaceutical ingredients for generic drugs. The new company, Active Pharma, is based in Tokyo and will provide APIs for Nichi-Iko, which is seeing an expanded market for its generic drugs. The new company will acquire Mitani's wholly owned API maker Sagami Chemicals. Known for making ingredients for hyperlipidemia drugs, Sagami's sales were ¥2.2 billion in fiscal year 2008. (Click here for more - Japanese language
You may also be interested in...
Increasing savvy around cybersecurity issues is driving regulators and trade groups to update their approach to the area, speakers from the US FDA and the American Medical Association said at this week’s FDA/CMS Summit.
Recent and upcoming US FDA advisory committee meetings and a summary of topics covered.